View in EDS

LONG-TERM SAFETY AND EFFICACY OF MAVACAMTEN IN PATIENTS (PTS) WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM): UPDATED RESULTS FROM THE PIONEER-OLE STUDY.

Saved in:
Bibliographic Details
Title: LONG-TERM SAFETY AND EFFICACY OF MAVACAMTEN IN PATIENTS (PTS) WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM): UPDATED RESULTS FROM THE PIONEER-OLE STUDY.
Authors: Masri, Ahmad1 (AUTHOR), Lester, Steven J.1 (AUTHOR), Stendahl, John1 (AUTHOR), Hegde, Sheila M.1 (AUTHOR), Sehnert, Amy1 (AUTHOR), Balaratnam, Ganesh1 (AUTHOR), Fox, Shawna1 (AUTHOR), Wang, Andrew1 (AUTHOR)
Source: Journal of the American College of Cardiology (JACC). 2023 Supplement, Vol. 81, p346-346. 1p.
Database: Academic Search Ultimate
Description
ISSN:07351097
DOI:10.1016/S0735-1097(23)00790-8